Skip to main content
Veterinary Medicines

Dycoxan 2.5 mg/ml Oral Suspension for sheep and cattle

Authorised
  • Diclazuril

Product identification

Medicine name:
Dycoxan 2.5 mg/ml Oral Suspension for sheep and cattle
Active substance:
  • Diclazuril
Target species:
  • Cattle (calf)
  • Sheep (lamb)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Diclazuril
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AJ03
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • box containing 1 bottle of 5 L
  • box containing 1 bottle of 2,5 L
  • box containing 1 bottle of 1 L
  • box containing 1 bottle of 200 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 666/19/06/2068
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0367/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

eu-PUAR-esv0367001-dcp-dycoxan-2.5-mg-ml-oral-suspension-for-sheep-and-cattle-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."